Harmony Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$380K Sell
15,783
-1,565
-9% -$40.9K 0.1% 147
2026
Q1
$487K Buy
17,348
+258
+2% +$6.87K 0.15% 126
2025
Q4
$426K Buy
17,090
+224
+1% +$5.65K 0.14% 121
2025
Q3
$430K Hold
16,866
0.15% 121
2025
Q2
$409K Hold
16,866
0.15% 122
2025
Q1
$427K Sell
16,866
-107
-0.6% -$2.8K 0.18% 113
2024
Q4
$450K Buy
16,973
+2,042
+14% +$55.4K 0.18% 108
2024
Q3
$432K Buy
14,931
+2,309
+18% +$67.4K 0.16% 113
2024
Q2
$353K Buy
+12,622
New +$348K 0.15% 114

Other funds holding PFE

Harmony Asset Management's PFE Position: Q2 2026 in Review

Harmony Asset Management reduced its Pfizer (PFE) stake by 9% in Q2 2026, selling an estimated $40.9K and leaving 15,783 shares worth $380K. The position accounts for 0.1% of the portfolio, ranked #147.

Harmony Asset Management first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $487K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Harmony Asset Management held 15,783 shares of Pfizer worth $380K as of Q2 2026.
  • Harmony Asset Management sold 1,565 Pfizer shares in Q2 2026, an estimated $40.9K.
  • Pfizer made up 0.1% of Harmony Asset Management's portfolio in Q2 2026, its #147 holding.
  • Harmony Asset Management first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
  • Harmony Asset Management's Pfizer position peaked at $487K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Harmony Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.